| | Business Summary | | Zimmer
Holdings,
Inc.,
formerly
Zodiac
Holdings,
Inc.,
is
engaged
in
the
design,
development,
manufacturing
and
marketing
of
orthopedic
reconstructive
implants
and
fracture
management
products.
Orthopedic
reconstructive
implants
restore
joint
function
lost
due
to
disease
or
trauma
in
joints
such
as
knees,
hips,
shoulders
and
elbows.
Fracture
management
products
are
devices
used
primarily
to
reattach
or
stabilize
damaged
bone
and
tissue
to
support
the
body's
natural
healing
process.
The
Company
also
manufactures
and
markets
other
products
relating
to
orthopedic
and
general
surgery.
The
Company
has
operations
in
approximately
20
countries
and
markets
its
products
in
approximately
70
countries,
with
the
United
States
accounting
for
the
highest
percentage
of
its
sales.
Zimmer
Holdings
was
spun-off
from
Bristol-Myers
Squibb
on
August
7,
2001. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Zimmer
Holdings,
Inc.
is
engaged
in
the
design,
development,
manufacturing
and
marketing
of
orthopaedic
reconstructive
implants
and
fracture
management
products,
including
artificial
knees,
hips
and
other
joints.
For
the
six
months
ended
6/30/01,
net
sales
rose
13%
to
$580.3
million.
Net
income
fell
8%
to
$79.2
million.
Results
reflect
increased
sales
of
knees
and
hips,
offset
by
lower
gross
margins
and
increased
selling
and
research
and
development
expenses. | | More
from
Market Guide: Significant
Developments |
| | Officers | | J. Raymond
Elliott,
Chmn./Pres./CEO
Sam
R. Leno,
Sr. VP/CFO
Roy
D. Crowninshield,
VP/CSO
Sheryl
L. Conley,
VP
James
T. Crines,
VP/Contr. | More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/z/zmh.gif)